Arrowstreet Capital’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-153,062
| Closed | -$2.1M | – | 1941 |
|
|
2024
Q4 | $2.1M | Sell |
153,062
-24,519
| -14% | -$336K | ﹤0.01% | 1265 |
|
|
2024
Q3 | $4.86M | Buy |
+177,581
| New | +$4.86M | ﹤0.01% | 966 |
|
|
2021
Q1 | – | Sell |
-18,264
| Closed | -$361K | – | 2426 |
|
|
2020
Q4 | $361K | Sell |
18,264
-515,954
| -97% | -$10.2M | ﹤0.01% | 2082 |
|
|
2020
Q3 | $6.97M | Sell |
534,218
-308,782
| -37% | -$4.03M | 0.01% | 995 |
|
|
2020
Q2 | $9.56M | Buy |
+843,000
| New | +$9.56M | 0.02% | 791 |
|
|
2020
Q1 | – | Sell |
-22,900
| Closed | -$624K | – | 2022 |
|
|
2019
Q4 | $624K | Buy |
+22,900
| New | +$624K | ﹤0.01% | 1449 |
|
|
2018
Q4 | – | Sell |
-114,429
| Closed | -$5.26M | – | 1447 |
|
|
2018
Q3 | $5.26M | Buy |
114,429
+98,429
| +615% | +$4.53M | 0.01% | 500 |
|
|
2018
Q2 | $598K | Sell |
16,000
-12,248
| -43% | -$458K | ﹤0.01% | 887 |
|
|
2018
Q1 | $835K | Sell |
28,248
-29,252
| -51% | -$865K | ﹤0.01% | 897 |
|
|
2017
Q4 | $1.98M | Buy |
+57,500
| New | +$1.98M | ﹤0.01% | 824 |
|
|
2016
Q2 | – | Sell |
-49,657
| Closed | -$1.86M | – | 1443 |
|
|
2016
Q1 | $1.86M | Buy |
+49,657
| New | +$1.86M | 0.01% | 836 |
|
|
2015
Q3 | – | Sell |
-66,829
| Closed | -$2.27M | – | 1443 |
|
|
2015
Q2 | $2.27M | Buy |
+66,829
| New | +$2.27M | 0.01% | 606 |
|
|
2014
Q1 | – | Sell |
-166,872
| Closed | -$3.5M | – | 1261 |
|
|
2013
Q4 | $3.5M | Sell |
166,872
-17,307
| -9% | -$363K | 0.02% | 530 |
|
|
2013
Q3 | $4.33M | Buy |
184,179
+102,430
| +125% | +$2.41M | 0.03% | 406 |
|
|
2013
Q2 | $2.2M | Buy |
+81,749
| New | +$2.2M | 0.02% | 443 |
|